Predicted to enable cysteine-type endopeptidase activity. Acts upstream of or within several processes, including axon regeneration; negative regulation of bone mineralization; and negative regulation of osteoblast differentiation. Is expressed in several structures, including cardiovascular system; immature eye; mesoderm; nervous system; and pleuroperitoneal region. Orthologous to human LGMN (legumain).